RARE LIVER DISEASE CONFERENCE
This program is another opportunity for the Community Liver Alliance to help clinicians, service providers, patients and their caregivers to understand the rarer diseases that affect the liver including Autoimmune Hepatitis, PBC, PSC and pediatric liver disease. The program will educate both clinicians and patients on these diseases, current and pipeline therapies, resources, and provide networking opportunities with the region's liver experts through concurrent patient and provider sessions.
LIVER CANCER CONFERENCE
The goal of the Liver Cancer Conference is to help clinicians and other service providers understand the management of Hepatocellular Carcinoma in the US population, innovations in therapies, and advances in research and development. This program is directed to providers, patients, and caregivers. Concurrent educational sessions will be held for hepatologists, gastroenterologists, oncologists, primary care physicians and other health care providers involved in the management of patients with liver cancer. A separate session will be geared towards patients and their caregivers.
PEDIATRIC LIVER CONFERENCE
The Pediatric Liver Conference brings together small case Pediatric Liver Specialists and caregivers that are managing a child with liver disease or transplant. The conference will focus on recent advances in the diagnosis and management of children with a wide variety of liver diseases. We will also hear from other caregivers who have firsthand knowledge on how to care for a child with liver disease. There will be Q and A to help even the newest parent navigate the ins and outs of caring for your child.
LIVER JOURNAL CLUB
Our new Liver Journal Club series will be held each quarter. Topics include HCC/PBC, Fatty Liver/NASH, Viral Hepatitis, Cirrhosis, and other liver conditions. Presentations are given by medical fellows to an audience of their peers and other health providers to critically evaluate recent articles in the academic literature.
POST AASLD PROVIDER CONFERENCE
The goal of this CME program is to bring the key findings of the 2021 AASLD National Conference to the broader liver community to learn about current trends, management techniques, recent innovations, and research to treat a full range of liver conditions, including Fatty Liver/NASH, Hepatocellular Carcinoma, Cholestatic Diseases, Pediatric Liver Diseases and Liver Transplantation.
Developed in conjunction with PBC patients, this educational program will include up-to-date information about PBC treatments, developments, clinical trials, transplantation, nutrition, resources, support, and more.
The goal of PBC Update is to educate, connect, and support patients, caregivers, and providers in an open, informative setting through concurrent patient and provider sessions.
The Transplant Update features world-class speakers providing cutting-edge research and clinical information in transplant medicine. Information is provided to both clinicians and caregivers in separate, concurrent sessions.
The NASH Update is an annual interactive conference directed at the patient and caregiver. Content includes education about screening recommendations, lifestyle modification, current treatment options, drug trials, pediatric diseases, healthy cooking, and physical activity demonstrations. A concurrent provider CME session educates hepatologists, gastroenterologists, primary care physicians and other healthcare providers involved in the management of patients with liver disease about NASH/NAFLD, both pharmacologic and endoscopic, emerging nutritional and weight management research related to NASH/NAFLD, extra-hepatic manifestations associated with NASH, management options and screening options.
TREATING HCV IN A PRIMARY CARE SETTING PROVIDER TRAINING
The goal of this course module is to help clinicians and other service providers understand the local and regional picture of viral hepatitis, understand HCV screening recommendations, current treatment options, the diagnosis, how to treat HCV patients, and specific issues with vulnerable populations especially people who inject drugs, the opioid use disorder.